Medifron DBT Co. Ltd (065650) — Capital Reinvestment Ratio
Latest as of June 2025:
0.00x
Medifron DBT Co. Ltd (065650) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩6.72 Billion) in capital expenditures (₩22.85 Million). See Medifron DBT Co. Ltd (065650) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
₩6.72 Billion
KRW
Capital Expenditures
₩22.85 Million
KRW
Data as of
Jun 2025
Most recent filing
Medifron DBT Co. Ltd Capital Reinvestment Ratio (2011–2014)
This chart tracks Medifron DBT Co. Ltd's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Medifron DBT Co. Ltd (2011–2014)
Year-by-year Capital Reinvestment Ratio for Medifron DBT Co. Ltd from 2011 to 2014. For live market cap and broader valuation context, see 065650 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 38.34x | ₩701.96K | ₩26.91 Million | ▲ +129467.7% |
| 2011 | 0.03x | ₩912.56 Million | ₩27.00 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow